Skip to main content

Table 1 General characteristics of the patients with autoimmune hepatitis

From: Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis

Variables n = 97
Age (years) 54.0 ± 11.3
Female, n (%) 82 (84.5)
Autoantibodies positive, n (%) 83 (85.6)
ANA + , n (%) 78 (80.4)
ASMA + , n (%) 24 (24.7)
Anti-LKM1 + , n (%) 3 (3.1)
Anti-LC1, n (%) 2 (2.1)
Anti-SLA/LP, n (%) 2 (2.1)
IgG (g/L) 16.80 (13.35, 21.10)
ALT (U/L) 88.0 (32.0, 322.5)
AST (U/L) 113.0 (35.0, 401.0)
ALP (U/L) 110.0 (75.5, 151.0)
GGT (U/L) 125.9 (59.0, 248.0)
TBIL (μmol/L) 20.0 (12.7, 68.4)
ALB (g/L) 40.1 ± 5.6
PLT (× 109/L) 184.8 ± 70.5
PT (s) 13.2 ± 1.5
Iron (μmol/L) 27.7 ± 14.4
Transferrin (g/L) 2.67 (2.28, 3.17)
Ferritin (μg/L) 214.0 (78.0, 515.0)
UIBC (μmol/L) 31.2 (21.2, 48.2)
TIBC (μmol/L) 59.8 (53.8, 68.9)
TSI (%) 43.6 (28.2, 64.2)
AIH score (1999) 15.8 ± 2.7
AIH score (2008) 7.5 ± 1.3
Histology (inflammation), n (%)
 G0 0 (0)
 G1 3 (3.1)
 G2 42 (43.3)
 G3 40 (41.2)
 G4 12 (12.4)
Histology (fibrosis), n (%)
 F0 11 (11.3)
 F1 22 (22.7)
 F2 26 (26.8)
 F3 21 (21.6)
 F4 17 (17.5)
  1. Data are expressed as mean (± standard deviation), median (quartile 25, quartile 75) or number (proportion)
  2. ANA antinuclear antibody, ASMA anti-smooth muscle antibody, Anti-LKM1 anti-liver kidney microsomal antibody type 1, Anti-LC1 anti-liver cytosol type 1 antibody, Anti-SLA/LP anti-soluble liver antigen or anti-liver-pancreas antibodies, IgG immunoglobulin G, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, GGT gamma-glutamyl transpeptidase, TBIL total bilirubin, ALB albumin, PLT platelet, PT prothrombin time, UIBC unsaturated iron binding capacity, TIBC Total iron binding capacity, TSI transferrin saturation index